BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meier NR, Volken T, Geiger M, Heininger U, Tebruegge M, Ritz N. Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis. Front Pediatr 2019;7:208. [PMID: 31192175 DOI: 10.3389/fped.2019.00208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Vukugah TA, Ntoh VN, Akoku DA, Leonie S, Jacob A, Asante-poku A. Research Questions and Priorities for Pediatric Tuberculosis: A Survey of Published Systematic Reviews and Meta-Analyses. Tuberculosis Research and Treatment 2022;2022:1-10. [DOI: 10.1155/2022/1686047] [Reference Citation Analysis]
2 Howard-Jones AR, Marais BJ. Tuberculosis in children: screening, diagnosis and management. Curr Opin Pediatr 2020;32:395-404. [PMID: 32374579 DOI: 10.1097/MOP.0000000000000897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Robert M, Miossec P. Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor. Cell Mol Immunol 2021;18:1644-51. [PMID: 34021269 DOI: 10.1038/s41423-021-00694-9] [Reference Citation Analysis]
4 Girishan Prabhu V, Taaffe KM, Pirrallo RG, Shvorin D. A data driven policy to minimise the tuberculosis testing cost among healthcare workers. Health Planning & Management. [DOI: 10.1002/hpm.3496] [Reference Citation Analysis]
5 Nolt D, Starke JR. Tuberculosis Infection in Children and Adolescents: Testing and Treatment. Pediatrics 2021;148:e2021054663. [PMID: 34851422 DOI: 10.1542/peds.2021-054663] [Reference Citation Analysis]
6 Buonsenso D, Delogu G, Perricone C, Grossi R, Careddu A, De Maio F, Palucci I, Sanguinetti M, Valentini P, Sali M. Accuracy of QuantiFERON-TB Gold Plus Test for Diagnosis of Mycobacterium tuberculosis Infection in Children. J Clin Microbiol 2020;58:e00272-20. [PMID: 32229602 DOI: 10.1128/JCM.00272-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
7 Starke JR, Erkens C, Ritz N, Kitai I. Strengthening Tuberculosis Services for Children and Adolescents in Low Endemic Settings. Pathogens 2022;11:158. [DOI: 10.3390/pathogens11020158] [Reference Citation Analysis]
8 van Loon W, Gomez MP, Jobe D, Franken KLMC, Ottenhoff THM, Coninx M, Kestens L, Sutherland JS, Kampmann B, Tientcheu LD. Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in The Gambia. BMC Infect Dis 2020;20:469. [PMID: 32615981 DOI: 10.1186/s12879-020-05194-1] [Reference Citation Analysis]
9 Kim KH, Kang JM, Ahn JG. Low-dose steroids are associated with indeterminate QuantiFERON-TB Gold In-Tube assay results in immunocompetent children. Sci Rep 2021;11:6468. [PMID: 33742079 DOI: 10.1038/s41598-021-86053-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yang Q, Zhang C, Ruan Q, Zhang W, Zhang H, Li Y, Shao L, Zhang W. Higher T-SPOT.TB threshold may aid in diagnosing active tuberculosis?: A real-world clinical practice in a general hospital. Clin Chim Acta 2020;509:60-6. [PMID: 32505775 DOI: 10.1016/j.cca.2020.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Goletti D, Delogu G, Matteelli A, Migliori GB. The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection. Int J Infect Dis 2022:S1201-9712(22)00126-6. [PMID: 35257904 DOI: 10.1016/j.ijid.2022.02.047] [Reference Citation Analysis]
12 von Both U, Gerlach P, Ritz N, Bogyi M, Brinkmann F, Thee S. Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland. PLoS One 2021;16:e0250387. [PMID: 33970930 DOI: 10.1371/journal.pone.0250387] [Reference Citation Analysis]
13 Zubarioglu T, Bayraktar B, Dalgic N, Sancar M, Cakir E, Togay A, Gencer H, Bulut E, Yalciner A. Evaluation of QuantiFERON tuberculosis Gold In-Tube assay for diagnosis of active tuberculosis in children. J Paediatr Child Health 2020;56:581-5. [PMID: 31714643 DOI: 10.1111/jpc.14687] [Reference Citation Analysis]
14 Soler-Garcia A, Gamell A, Pérez-Porcuna T, Soriano-Arandes A, Santiago B, Tórtola T, Ruiz-Serrano MJ, Korta Murua JJ, Bustillo-Alonso M, Garrote-Llanos MI, Rodríguez-Molino P, Piqueras AI, Tagarro A, Monsonís M, Tebruegge M, Noguera-Julian A; QFT-Plus Study Group of the Spanish Pediatric TB Research Network. Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study. Thorax 2021:thoraxjnl-2021-217592. [PMID: 34876500 DOI: 10.1136/thoraxjnl-2021-217592] [Reference Citation Analysis]
15 Bamford A, Dixon G, Klein N, Marks SD, Ritz N, Welch SB, Tebruegge M. Preventing tuberculosis in paediatric kidney transplant recipients: is there a role for BCG immunisation pre-transplantation in low tuberculosis incidence countries? Pediatr Nephrol 2020. [PMID: 33245418 DOI: 10.1007/s00467-020-04844-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Lu Y, Chen Y, Peng X, Yao J, Zhong W, Li C, Zhi M. Development and validation of a new algorithm model for differential diagnosis between Crohn's disease and intestinal tuberculosis: a combination of laboratory, imaging and endoscopic characteristics. BMC Gastroenterol 2021;21:291. [PMID: 34256708 DOI: 10.1186/s12876-021-01838-x] [Reference Citation Analysis]